Author:
Szwed Marzena,Jozwiak Zofia
Subject
Health, Toxicology and Mutagenesis,Genetics
Reference37 articles.
1. Chronic myeloid leukemia with an unusual paraneoplastic syndrome;Sharma;J. Assoc. Physicians India,2012
2. The role of peptide and DNA vaccines in myeloid leukemia immunotherapy;Lin;Cancer Cell. Int.,2013
3. Tyrosine kinase targeted treatment of chronic myelogenous leukemia and other myeloproliferative neoplasms;Bisen;Adv. Exp. Med. Biol.,2013
4. Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients;Elias;Hematol. Rep.,2012
5. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair;Majsterek;Mutat. Res.,2006
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献